On World Cervical Cancer Elimination Day, WHO is calling for stronger integration of HIV and cervical cancer services to ensure that women and girls living with HIV receive timely prevention, screening, diagnosis and treatment of cervical cancer. A coordinated person-centred approach can reduce deaths, improve health outcomes and contribute to an improved quality of life.
Women living with HIV have a disproportionate burden of cervical cancer, with a six-fold higher risk of developing cervical cancer than women without HIV. Women living with HIV can also experience poorer outcomes, including a higher risk of death 1–2 years after diagnosis and a three-fold greater likelihood of residual tumours following radiotherapy.
Despite these challenges, global progress to prevent and detect cervical cancer is accelerating. When women living with HIV are receiving antiretroviral therapy (ART) at the start of their cervical cancer treatment, mortality differences are no longer significant. Over 50% of girls in the WHO African Region, the region with the highest burden, received at least one dose of human papillomavirus (HPV) vaccine in 2025, and around 133 countries globally have introduced cervical cancer screening. The challenge is to ensure that these life-saving services reach every woman and girl, including those who are living with HIV.